Skip to content

Genetic and Histopathologic Characteristics of Interstitial Cystitis

Genetic and Histopathologic Characteristics of Interstitial Cystitis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03523559
Enrollment
14
Registered
2018-05-14
Start date
2018-03-31
Completion date
2024-02-29
Last updated
2024-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Interstitial Cystitis

Brief summary

Genetic and Histopathologic Characteristics of Interstitial Cystitis

Interventions

GENETICbladder tissue of Interstitial Cystitis and normal bladder tissue

Obtain the bladder tissue of Interstitial Cystitis and normal during the operation

Sponsors

Samsung Medical Center
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male and female aged 19 yrs or greater * Patients diagnosed with Hunner lesion in Interstitial cystitis and who is scheduled to undergo transurethral resection * Patients diagnosed with Bladder cancer and who is scheduled to undergo cystectomy

Exclusion criteria

* Male and female under aged 20 yrs * A person whose area of bladder cancer is larger than that of the normal area * A person who is going to have a cystectomy after chemotherapy on bladder cancer

Design outcomes

Primary

MeasureTime frame
Genetic differences between ulcer and non-ulcer of bladder in Interstitial Cystitis30days
Genetic differences between bladder tissue of Interstitial Cystitis and normal bladder tissue30days

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026